4.1 Article

Access to orphan drugs in Europe: current and future issues

Related references

Note: Only part of the references are listed.
Review Genetics & Heredity

Pricing and reimbursement of orphan drugs: the need for more transparency

Steven Simoens

ORPHANET JOURNAL OF RARE DISEASES (2011)

Article Economics

Drugs for Rare Diseases: Influence of Orphan Designation Status on Price

Eline Picavet et al.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2011)

Review Pharmacology & Pharmacy

Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products

James W. Dear et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)